See every side of every news story

Published 9 days ago • loading... • Updated 9 days ago

Celcuity’s shares rally after ESMO readouts; Disc Medicine’s $220M stock sale

Summary by endpoints.news

Plus, news about Novo Nordisk, Amgen, AstraZeneca, Viridian Therapeutics, Alto Neuroscience and Siren Biotechnology: 📈 Celcuity’s stock soars after ESMO readouts in breast cancer: After Roche presented its #ESMO25 readout for giredestrant ...

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

Celcuity’s shares rally after ESMO readouts; Disc Medicine’s $220M stock sale

Plus, news about Novo Nordisk, Amgen, AstraZeneca, Viridian Therapeutics, Alto Neuroscience and Siren Biotechnology: 📈 Celcuity’s stock soars after ESMO readouts in breast cancer: After Roche presented its #ESMO25 readout for giredestrant ...

9 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated9 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in 9 days ago on Monday, October 20, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics